Ø Bleie

Summary

Affiliation: Haukeland University Hospital

Country: Norway

Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease
Ø Bleie
Department of Heart Disease, Haukeland University Hospital, Bergen, Norway
J Intern Med 262:244-53. 2007
Coronary blood flow in patients with stable coronary artery disease treated long term with folic acid and vitamin B12
Øyvind Bleie
Department of Heart Disease, Haukeland University Hospital, Bergen, Norway
Coron Artery Dis 22:270-8. 2011
Combined analyses and extended follow-up of two randomized controlled homocysteine-lowering B-vitamin trials
M Ebbing
Department of Heart Disease, Haukeland University Hospital, Bergen, Norway
J Intern Med 268:367-82. 2010

Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease
Ø Bleie
Department of Heart Disease, Haukeland University Hospital, Bergen, Norway
J Intern Med 262:244-53. 2007
..We wanted to test the effect of homocysteine-lowering B-vitamin therapy, as used in the Western Norway B-vitamin Intervention Trial (WENBIT), on inflammatory markers associated with atherosclerosis...
Coronary blood flow in patients with stable coronary artery disease treated long term with folic acid and vitamin B12
Øyvind Bleie
Department of Heart Disease, Haukeland University Hospital, Bergen, Norway
Coron Artery Dis 22:270-8. 2011
..We wanted to examine the effects of B-vitamin therapy, which may lower total homocysteine, on coronary flow and vascular function in patients with established coronary artery disease (CAD)...
Combined analyses and extended follow-up of two randomized controlled homocysteine-lowering B-vitamin trials
M Ebbing
Department of Heart Disease, Haukeland University Hospital, Bergen, Norway
J Intern Med 268:367-82. 2010
....